Testing the Model for Predicting Effectiveness of Anakinra in Systemic Juvenile Idiopathic Arthritis

J Rheumatol. 2019 Oct;46(10):1422-1424. doi: 10.3899/jrheum.190238. Epub 2019 Jun 15.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antirheumatic Agents*
  • Arthritis, Juvenile*
  • Humans
  • Interleukin 1 Receptor Antagonist Protein
  • Severity of Illness Index

Substances

  • Antirheumatic Agents
  • Interleukin 1 Receptor Antagonist Protein